MBX - Company ID 0001776111
The table below shows MBX Biosciences, Inc.'s balance sheet line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Cash & equivalents | $75.29M | $49.35M |
| Short-term investments | $298.42M | $212.80M |
| Receivables | - | - |
| Inventory | - | - |
| Total current assets | $381.54M | $267.29M |
| Property, plant & equipment | $2.73M | $1.08M |
| Goodwill | - | - |
| Total assets | $385.14M | $268.54M |
| Accounts payable | $2.98M | $5.33M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current liabilities |
| $15.49M |
| $11.05M |
| Long-term debt | - | - |
| Total liabilities | $15.92M | $11.09M |
| Retained earnings | -$224.48M | -$137.50M |
| Total equity | $369.22M | $257.44M |